Buy, sell, hold: Investing tips on 8 largecap stocks post Q2 nos

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

live

• bselive
• nselive

Volume

Todays L/H

More

×

Moneycontrol Bureau Here are investing ideas on 8 large cap stocks post September quarter results. Jubilant Food Bank of America Merrill Lynch maintains buy call with target price of Rs 1320 per share. It says the company is likely to target volume-led growth with focus on better pricing and promotion while economical launches to continue to drive same stores sales growthJP Morgan is overweight on the stock with target price increased to Rs 1190 per share from Rs 1155 per share. Nomura maintains reduce call with target price revised to Rs 890 per share from Rs 900 per share.  It has cut FY17F/FY18F/FY19F EPS estimates by 7.3 percent/11.9 percent/14.6 percent respectively. CLSA maintain buy call with target price of Rs 1450 per share but cuts FY17-19 EPS by 13-19 percent and reduce same store sales growth forecasts.

HUL CLSA cuts FY17-19 EPS by 1-2 percent but revised target to Rs 930 per share from Rs 885 per share and upgraded to outperform. The management is fairly confident of a gradual recovery ahead.Macquarie cuts FY17/18 earnings by 12-13 percent on  lower revenue and margin assumptions but maintains outperform. It has cut target to Rs 916 per share from Rs 940 per share.

Deutsche Bank retains hold rating with target at Rs 890 per share as Q2 performance reflects the struggle  in implementing price increase

Bank of America Merrill Lynch reiterates buy rating with target unchanged at Rs 1020 per share.  Nomura cuts FY17/18/19 EPS by 7.7 percent /12.4 percent /9.7 percent and target cut to Rs 983 per share from Rs 1076 per share.

Citi has a sell call on the stock with target at Rs 830 per share.

Goldman Sachs has neutral call on the stock with target cut to Rs 692 per share from Rs 703 per share.

Hero MotoCorp CLSA reiterate sell call with a target of Rs 3030 per share as Q2 results expectedly strong given strong volume growth but finds  valuations at 17x 18 PE  are expensive. Morgan Stanley has equal-weight rating with target at Rs 3239 per share.Torrent Pharma Credit Suisse maintain outperform rating with target cut to Rs 1770 per share from Rs 1950 per share. Dabur Credit Suisse maintains neutral but target cut  to Rs 275 per share from Rs 280 per share as earnings growth may slip to low-singledigits if revenue growth does not pick up. Citi has a buy rating with target at Rs 325 per share. It says valuations at 15-20 percent discount  to sector with similar growth.

Cadila Health Credit Suisse maintains neutral with target unchanged at Rs 405 per share.

CLSA upgrade it to buy from underperform with target revised to Rs 470 per share from Rs 360 share as low base of FY17 favourable to  drive robust earnings growth.

Exide Goldman Sachs maintains neutral rating with target increased to Rs 192 per share from Rs 185 per share and increased FY17-19 EPS estimates by 4-5 percent.

Morgan Stanley has equal-weight rating with target at Rs 160 percent stating that margin could be under pressure in Q3.

HDFC Citi has a buy rating on the stock with target at Rs 1640 per share. It sees structural momentum, tailwinds  beginning to show through.Posted by Nasrin Sultana